Market Overview

Merz Names Kristina Yu-Isenberg, Ph.D., Vice President of Medical Affairs North America


Merz today announced Kristina Yu-Isenberg, Ph.D., M.P.H, R.Ph., has been
named Vice President of Medical Affairs North America, effective
immediately. Dr. Yu-Isenberg oversees medical affairs in North America
and is located in the Merz North America headquarters in Raleigh, North

This press release features multimedia. View the full release here:

Kristina Yu-Isenberg, Ph.D., joins Merz as Vice President of Medical Affairs North America (Photo: B ...

Kristina Yu-Isenberg, Ph.D., joins Merz as Vice President of Medical Affairs North America (Photo: Business Wire)

"Dr. Yu-Isenberg brings to Merz more than two decades of diverse medical
affairs experience and a proven track record of leading innovative and
high performing teams," said Dr. Terri Phillips, vice president and head
of global medical affairs at Merz. "I am confident her combined
experience as a medical affairs leader, researcher and published author
will help Merz maximize the clinical potential of our products and
pipeline while improving patients' health and quality of life."

In her new role, Dr. Yu-Isenberg is responsible for leading the medical
affairs strategy in the U.S., working closely with the Canada and Latin
America teams. She reports to Dr. Phillips, who joined Merz in January
2018 to build and enhance the company's medical affairs function.

"We are delighted to welcome Dr. Yu-Isenberg to Merz," said Bob
Rhatigan, CEO of Merz North America. "Dr. Yu-Isenberg joins our team of
experienced executives and demonstrates Merz's commitment to attracting
top industry talent to help our patients live better, feel better and
look better."

"I am thrilled to join the team at Merz and have the opportunity to
further link scientific, clinical and real-world evidence for positive
patient outcomes," said Dr. Yu-Isenberg. "Dr. Phillips has already made
significant impact in building and enhancing Merz's medical affairs
function since joining the company earlier this year. I am looking
forward to continuing the momentum to support her goals and bring
high-quality scientific knowledge to educate health care providers,
customers and patients about our comprehensive product portfolio."

Prior to joining Merz, Dr. Yu-Isenberg served as head and vice president
of evidence generation and analytics, global medical affairs at Intarcia
Therapeutics. She began her industry career at GlaxoSmithKline and has
taken on positions of increasing responsibility and scope within U.S.
and global medical affairs teams, as well as in Health Economics and
Outcomes Research (HEOR) at Janssen Pharmaceuticals, Novartis
Pharmaceuticals and Biogen.

Dr. Yu-Isenberg received her Ph.D. in health services research from The
Johns Hopkins Bloomberg School of Public Health. She received a master's
degree in public health from University of Massachusetts at Amherst and
a bachelor's degree in science from University of North Carolina
Eshelman School of Pharmacy. She is a registered pharmacist in North
Carolina and served in the U.S. public health service as a lieutenant.
As a research grant awardee of The National Institutes of Health, she
has been acknowledged for innovation and high performance across
multiple teams and organizations.

Dr. Yu-Isenberg is also the author of numerous publications on patient
adherence and patient-reported outcomes, as well as comparative
effectiveness, economic evaluations and real-world evidence. She is
currently a member of the AARP Mayo Clinic Diabetes Quality Measure
Working Group, has served as a member of the National Quality Forum
Steering Committee for Ambulatory Care Measures and was co-chair of the
Research Coordinating Council for the Pharmacy Quality Alliance.

About Merz North America, Inc.

Merz North America, Inc. is a speciality healthcare company dedicated to
the development and marketing of innovative quality products for
physicians and patients across the United States and Canada. Merz
products are distributed through two divisions, Aesthetics and
Neurosciences, and are developed with the goal of improving patients'
health and quality of life by delivering therapies that bring about real
progress. Privately-held, Merz North America is headquartered in
Raleigh, North Carolina. To learn more about Merz North America, Inc.,
please visit

View Comments and Join the Discussion!